Should you buy CGC stock after marijuana reclassification?
Canopy Growth Corporation CGC is back in focus as marijuana reclassification efforts revive investor interest in cannabis stocks. While the regulatory shift has improved sentiment across the sector, …
‘Devastating’: Retired firefighter says he lost most of his retirement savings investing in stocks that were targeted by a famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Retired firefighter says he lost most of his savings investing in stocks that were targeted by famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Canopy Growth’s Stock Just Dropped — Here’s Why I’m Still Not Buying
For anyone who has observed Canopy Growth (NASDAQ: CGC) during the past few years, it won’t be shocking to learn that the marijuana company’s stock is diving in May. Since the start of the month, it’s …
Auxly Cannabis is still undervalued, this analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $0.25 target on Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, Chart, News, Analysts, Financials TSX:XLY) in a May 14 report after …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Cannabis Has Dozens Of Public Companies. Wall Street Acts Like It Has Seven.
Cannabis stocks have rallied 104% in a year, but only seven North American operators clear the institutional threshold that matters to Wall Street.
Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
Robinhood Is Opening the Door to U.S. Cannabis With Reform On the Horizon
Trulieve, Curaleaf, and Green Thumb Industries showed up on the app this week as the federal government inches toward reclassifying recreational marijuana.
Cannabis, Wellness And Beverages: Three Names To Watch
Tilray, Canopy Growth and Cronos are three US-listed names at the intersection of cannabis, wellness and beverages.
This weed stock is undervalued, analyst says
The analyst expects Trulieve to generate Adjusted EBITDA of US$401.1-million on revenue of US$1.178-billion in fiscal 2026, improving to US$415.8-million on revenue of US$1.221-billion in fiscal 2027.
Here’s why Tilray Brands stock has crashed after cannabis reclassification
Tilray Brands stock price crashed to its lowest level since August last year despite the recent US policy change that opened the door to its expansion in the country. TLRY dropped to $5.6, much lower …
Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?
Although cannabis stocks have not performed well over the past five years, there is still some hope left for the industry. According to some projections, the market will continue …
Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled
Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin, and places it in the same ca …
Cannabis ETFs: Regulatory Momentum Returns Focus
Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow but differentiated thematic play on potential regulatory upside.
Recent Comments